Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program (NCT05008848) | Clinical Trial Compass
RecruitingPhase 3
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
United States600 participantsStarted 2022-04-01
Plain-language summary
This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Have a cancer diagnosis within the past 10 years, and can currently be receiving curative treatment
* Not currently on hospice
* Currently smokes \>= 5 cigarettes daily
* Lives in a nonmetro/rural county (defined as having a Rural Urban Continuum Code \[RUCC\] code of 4-9)
* Patient interested in participating in a smoking cessation program, and not currently participating in a smoking cessation clinical trial
* Not currently using any smoking cessation pharmacotherapy (e.g. nicotine replacement therapy, bupropion or varenicline), or currently participating in any cessation program
* Patient has a cell phone or smart phone device with texting ability
* In order to complete the mandatory patient-completed measures, participants must be able to speak and read English
* Age \>= 18 years
* Participant must be willing to provide a urine sample.
Exclusion Criteria:
* Psychiatric illness which would prevent the patient from giving informed consent
* Patients with impaired decision-making capacity are not eligible for this study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses a text-based smoking cessation program specifically designed for rural cancer survivors — given my situation and where I live, does my doctor think this kind of remote, phone-based approach could realistically work for me compared to in-person cessation support?
2Since this is a Phase 3 trial, what does that mean for what's already known about the safety and effectiveness of text-message quit-smoking programs, and is there anything still uncertain that I should weigh before considering it?
3The trial measures 'biochemically validated tobacco cessation,' which means they'd verify whether I've actually quit smoking — what does that verification process involve, and how often would I need to provide samples or check in?
4Are there standard, proven smoking cessation treatments — like nicotine replacement therapy, prescription medications, or counseling — that my doctor would recommend I try first, or alongside this trial, rather than instead of it?
5If I'm already receiving active cancer treatment, could participating in a structured text-based cessation program fit into my current care schedule without adding too much burden, and does my doctor think quitting smoking now could affect my treatment outcomes?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.